Doximity Stock Down Despite Q2 Earnings Beat, Revenues Up Y/Y

Doximity (DOCS) surpassed fiscal Q2 2026 analyst expectations, reporting adjusted EPS of 45 cents, a 50% year-over-year increase, and revenues of $168.5 million, up 23.2% year-over-year, driven by strong subscription growth and AI product adoption. The company also raised its full fiscal year revenue guidance to $640-$646 million. Despite these positive results and gross margin expansion, the stock declined 8.9% in pre-market trading, likely influenced by a 100 basis point contraction in the operating margin to 37.8%.

Analysis

Doximity (DOCS) reported a strong fiscal Q2 2026, with adjusted EPS of 45 cents, a 50% year-over-year increase, significantly beating consensus estimates by 18.4%. Revenues grew 23.2% year-over-year to $168.5 million, also surpassing the Zacks Consensus Estimate by 6.8%, driven primarily by robust subscription revenue growth. The company further demonstrated confidence by raising its full fiscal year 2026 revenue guidance to a range of $640 million-$646 million, exceeding prior outlooks and current consensus.

The revenue strength was underpinned by a 118% net revenue retention rate and growth in large accounts, with 121 customers contributing over $500,000 and representing 84% of total revenues. Gross margin expanded 30 basis points to 90.3%, indicating efficient core service delivery. Strategic investments in AI, including DoxGPT integration and AI Scribe adoption, contributed to record engagement with over 650,000 unique prescribers utilizing various platform tools.

Despite these positive top-line results and raised guidance, DOCS shares experienced an 8.9% decline in pre-market trading. This negative market reaction likely stems from the 100 basis point contraction in the operating margin, which fell to 37.8% due to a substantial 88.5% year-over-year increase in general and administrative expenses, alongside higher R&D and sales and marketing costs.

The company's focus on AI-driven product updates and workflow expansion, which now represents 40% of bookings, suggests a strategic investment phase aimed at long-term growth and enhanced customer value. However, the associated increase in operating expenses is impacting near-term profitability metrics, creating a divergence between strong revenue performance and margin pressure.

Key Decisions for Investors

• Investors should closely monitor Doximity's operating expense trends and their impact on future operating margins, despite strong revenue growth and raised guidance.
• Consider the long-term implications of Doximity's significant investments in AI and product innovation, which are driving engagement and bookings, as these could be key growth catalysts.
• Evaluate the market's reaction to the operating margin contraction against the backdrop of robust top-line beats and strong customer retention metrics, which suggest underlying business health.
• Assess whether the current valuation adequately reflects both the company's strong revenue momentum and the increased operational costs associated with its growth strategy.